| Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments SN Lone, S Nisar, T Masoodi, M Singh, A Rizwan, S Hashem, W El-Rifai, ... Molecular cancer 21 (1), 79, 2022 | 538 | 2022 |
| Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents S Hashem, TA Ali, S Akhtar, S Nisar, G Sageena, S Ali, S Al-Mannai, ... Biomedicine & Pharmacotherapy 150, 113054, 2022 | 235 | 2022 |
| Extracellular vesicles as tools and targets in therapy for diseases MA Kumar, SK Baba, HQ Sadida, SA Marzooqi, J Jerobin, FH Altemani, ... Signal transduction and targeted therapy 9 (1), 27, 2024 | 222 | 2024 |
| Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications I Lakshmanan, MP Ponnusamy, MA Macha, D Haridas, PD Majhi, S Kaur, ... Journal of Thoracic Oncology 10 (1), 19-27, 2015 | 155 | 2015 |
| Claudin-1, a double-edged sword in cancer AA Bhat, N Syed, L Therachiyil, S Nisar, S Hashem, MA Macha, SK Yadav, ... International journal of molecular sciences 21 (2), 569, 2020 | 134 | 2020 |
| Cytokine‐and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy AA Bhat, S Nisar, M Singh, B Ashraf, T Masoodi, CP Prasad, A Sharma, ... Cancer Communications 42 (8), 689-715, 2022 | 114 | 2022 |
| Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy AA Bhat, P Yousuf, NA Wani, A Rizwan, SS Chauhan, MA Siddiqi, ... Signal transduction and targeted therapy 6 (1), 12, 2021 | 112 | 2021 |
| Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells R Vengoji, MA Macha, RK Nimmakayala, S Rachagani, JA Siddiqui, ... Journal of Experimental & Clinical Cancer Research 38, 1-13, 2019 | 111 | 2019 |
| Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer S Rachagani, MA Macha, N Heimann, P Seshacharyulu, D Haridas, ... Advanced drug delivery reviews 81, 16-33, 2015 | 108 | 2015 |
| Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy AA Bhat, S Nisar, S Maacha, TC Carneiro-Lobo, S Akhtar, KS Siveen, ... Molecular cancer 20, 1-20, 2021 | 107 | 2021 |
| Natural products: A hope for glioblastoma patients R Vengoji, MA Macha, SK Batra, NA Shonka Oncotarget 9 (31), 22194, 2018 | 107 | 2018 |
| Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments G Dagar, A Gupta, T Masoodi, S Nisar, M Merhi, S Hashem, R Chauhan, ... Journal of translational medicine 21 (1), 449, 2023 | 106 | 2023 |
| Prognostic significance of nuclear pSTAT3 in oral cancer MA Macha, A Matta, J Kaur, SS Chauhan, A Thakar, NK Shukla, SD Gupta, ... Head & neck 33 (4), 482-489, 2011 | 105 | 2011 |
| MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway MA Macha, S Rachagani, P Pai, S Gupta, WM Lydiatt, RB Smith, ... Oncogene 34 (13), 1698-1708, 2015 | 102* | 2015 |
| Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling MA Macha, S Rachagani, S Gupta, P Pai, MP Ponnusamy, SK Batra, ... Cancer letters 341 (2), 166-177, 2013 | 101 | 2013 |
| MicroRNAs (miRNAs) as biomarker (s) for prognosis and diagnosis of gastrointestinal (GI) cancers M A Macha, P Seshacharyulu, S Ram Krishn, P Pai, S Rachagani, M Jain, ... Current pharmaceutical design 20 (33), 5287-5297, 2014 | 95 | 2014 |
| MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1 S Rachagani, MA Macha, MP Ponnusamy, D Haridas, S Kaur, M Jain, ... Carcinogenesis 33 (10), 1953-1964, 2012 | 95 | 2012 |
| The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities U Mehraj, RA Ganai, MA Macha, A Hamid, MA Zargar, AA Bhat, ... Cellular Oncology, 1-21, 2021 | 94 | 2021 |
| Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy S Rachagani, MP Torres, S Kumar, D Haridas, M Baine, MA Macha, ... Journal of hematology & oncology 5, 1-12, 2012 | 86 | 2012 |
| Insights into the role of circRNAs: biogenesis, characterization, functional and clinical impact in human malignancies S Nisar, AA Bhat, M Singh, T Karedath, A Rizwan, SK Yadav, S Hashem, ... Frontiers in Cell and Developmental Biology 9, 18, 2021 | 84 | 2021 |
Ajaz BhatVanderbilt University Medical School , Sidra Medical and Research Center, Sylvester ComprehensiveVerified email at sidra.org